Skip to main content
Log In
Cart
Contact
Toggle search
Keyword search
Toggle navigation
Keyword search
Membership
Toggle
Membership
Benefits of Membership
Membership Categories
SNO Committees
Special Interest Tracks
Events
Toggle
Events
2023 SNO Annual Meeting
2023 SNO Pediatric Conference
2023 SNO/ASCO CNS Cancer Conference
2022 Annual Conference on CNS Clinical Trials and Brain Metastases
2022 Annual Meeting
Community Events
SNO Annual Meetings
Publications
Toggle
Publications
Neuro-Oncology
Neuro-Oncology Advances
Neuro-Oncology Practice
SNO Digest
WFNOS Website
Resources
Toggle
Resources
Funding & Grants
Fellowship Resources
Pediatric Fellowship Resources
Women and Diversity
Member to Member Surveys
Career Center
Guidelines Endorsement
Survivorship Care Plan
International Outreach
Patient Resources
SNO Guidance on COVID-19
SNOCares
Education
Toggle
Neuro-Oncology Academy
Neuro-Oncology Podcast
Annual Meeting Content
Public Policy
Toggle
Action Resources
Committee Items
Press
Monthly Newsletter
About
Toggle
About
News
History & Bylaws
Officers & Board
Staff
Media Inquiries
Platinum Supporters
Awards
Donations
Privacy Policy
Press
Home
»
Public Policy
»
Committee Action Items
Latest Committee Work
Appropriations for Fiscal Year 2021
The SNO Public Policy Committee continues to advocate for an increase in federal funding for the National Institutes of Health and the National Cancer Institute. A successful advocacy process in Fiscal Year 2020 brought large increases to both entities, benefiting the health and well-being of brain cancer patients across the United States. The SNO Public Policy Committee was also successful in working with Congress to secure binding language to prevent changes to indirect costs calculations for NIH grants.
Drug Pricing and Drug Price Gouging
Throughout the 116
th
Congress, both Democrats and Republicans have put a major focus on legislation to keep drug prices down and to prevent price gouging by pharmaceutical companies. Thus far, no specific proposal has been signed by the President as the parties continue to negotiate. SNO is continuing to work alongside committees of jurisdiction to provide the neuro-oncology community perspective.
COVID-19 Response and Stimulus Packages
The COVID-19 response legislation directly impacts hospitals and healthcare providers. Many have lost revenue due to the suspension of elective surgical procedures and the delay of other medical needs. The SNO Public Policy Committee is working to educate Congress on the impacts of COVID-19 for our members and how Congress can work to best support researchers and hospitals moving forward.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##